GlassScriptPhysician profile
Randy T Pardue
NPI 1770539512
$3,730.23
in general payments reported to CMS, 2019-2025
41 companies · $639 in 2025
The $639 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $168 · 2021: $434 · 2022: $596 · 2023: $724 · 2024: $1,003 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,348 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,347.88 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,075.29 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $398.75 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $377.19 | 2019-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $311.54 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $268.15 | 2019-2024 | Shingrix, Arexvy |
| Pfizer INC. | $156.51 | 2021-2025 | |
| Astellas Pharma US INC | $113.65 | 2019-2025 | Veozah |
| Lundbeck LLC | $93.57 | 2022-2025 | Vyepti |
| Seqirus USA INC | $87.38 | 2022-2024 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Dynavax Technologies Corporation | $66.99 | 2023-2025 | Heplisav-B |
| Inspire Medical Systems, INC. | $65.93 | 2023 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.86 | 2022-2025 | Jardiance, Ofev |
| Ironshore Pharmaceuticals INC. | $46.06 | 2019 | |
| Abbott Laboratories | $45.61 | 2022 | |
| Nevro Corp. | $34.90 | 2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Pardue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.